Researchers at OHSU discovered CTX biomarkers
Credit: OHSU News
From left: Gladis Reyes Pimentel, core scientist; Sonja Connor, M.S., R.D., L.D., professor emeritus; Andrea DeBarber, Ph.D.; Jenefer DeKoning, core scientist; Maya Fowler, assistant core scientist; and Igor Landais, Ph.D., VGTI quality system director. Researchers at OHSU discovered biomarkers essential to identifying and treating the disease CTX, which led to a clinical trial at OHSU that in February culminated in FDA approval of an effective treatment for patients. (OHSU/Christine Torres Hicks)